Laureate Pharma Honored as Emerging Life Sciences Company of the Year
Laureate Pharma, Inc. Logo. (PRNewsFoto/Laureate Pharma, Inc.)
PRINCETON, NJ UNITED STATES
Laureate recognized for its business growth, leadership team and service innovation by the Eastern Technology Council
PRINCETON, N.J., Nov. 20 /PRNewswire/ -- Laureate Pharma, Inc., a
full-service biopharmaceutical development and protein production company,
today announced that it has been named the "Emerging Life Science Company of
the Year" by The Eastern Technology Council, the largest technology and life
sciences trade association in the greater Philadelphia, PA region. The
company was honored for its innovation in services, achievement of milestones
and strength of its management team, at the ETC's annual Enterprise Awards
Gala at Philadelphia's Kimmel Center on November 18th.
Laureate is an established leader in the contract manufacture of clinical
supply of biopharmaceutical products that target diseases including various
types of cancer, autoimmune diseases, bone disorders and infectious diseases.
Over the past few years Laureate has demonstrated strong growth, expanding its
facility and manufacturing capacity as well as capabilities. Laureate has
achieved several milestones during its impressive history, including
commissioning a new pilot plant, and becoming EBITDA positive in 2007. In
addition, the company has signed major biopharmaceutical development and
manufacturing contracts and fill/finish agreements growing its market share
and boosting its revenue.
"We are honored to receive this prestigious Enterprise award from Eastern
Technology Council," said Robert Broeze, Ph.D., President and the Chief
Executive Officer of Laureate Pharma. "This is a tribute to our leadership,
and our talented and committed staff. It is a great recognition of our
world-class operations and our strategy for business success. The award
validates our commitment to the advancement in human health and our vision of
partnering with our clients to improve the quality of all the lives we touch."
The Enterprise Awards is the Eastern Technology Council's annual
celebration of regional life sciences and technology companies and their
leaders. The Emerging Life Science Company Award honors a company that has at
least four years of strong operating results and revenues less than $50
million. Key considerations for the award include product or service
innovation, strategic decisions that led to growth in revenues and/or
earnings, and demonstrated ability to raise capital and achieve profitability.
About Laureate Pharma, Inc.
Laureate Pharma is a full-service biopharmaceutical development and
protein production company located in Princeton, New Jersey. Laureate Pharma
offers superior bioprocessing services that accelerate new products from
development through production. Laureate provides a wide range of specialized
services from process design and development to full-scale cGMP production,
purification, aseptic filling, testing, validation, analytical services, and
regulatory support. Laureate is focused on two active segments of the
biopharmaceutical industry: monoclonal antibodies and recombinant protein
products. For more information, contact Michael Cavanaugh, Vice President
Sales, Marketing, and Business Development at (609) 919-3400, or
info@laureatepharma.com or visit www.laureatepharma.com.
